title: Improvement in achievement of lipid targets in France: Comparison of data from coronary patients in the DYSIS and DYSIS II studies.
authors: Department of Cardiology B, Toulouse Rangueil University Hospital (CHU), Toulouse, France; Department of Epidemiology and Public Health, UMR 1027, INSERM - Université de Toulouse, Toulouse, France. Electronic address: jean.ferrieres@univ-tlse3.fr.
authors: Jean
authors: J
authors: Ferrières
authors: Merck and Co Inc, Kenilworth, USA.
authors: Maja Velkovski
authors: MV
authors: Rouyer
authors: Merck and Co Inc, Kenilworth, USA.
authors: Dominik
authors: D
authors: Lautsch
authors: Merck and Co Inc, Kenilworth, USA.
authors: Baishali M
authors: BM
authors: Ambegaonkar
authors: Institut fuer Herzinfarktforschungforschung Ludwigshafen, Ludwigshafen, Germany.
authors: Martin
authors: M
authors: Horack
authors: Merck and Co Inc, Kenilworth, USA.
authors: Philippe
authors: P
authors: Brudi
authors: Institut fuer Herzinfarktforschungforschung Ludwigshafen, Ludwigshafen, Germany; Herzzentrum Ludwigshafen, Medizinische Klinik B, Kardiologie, Ludwigshafen, Germany.
authors: Anselm K
authors: AK
authors: Gitt
mesh_terms: D000124:Achievement; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009017:Morbidity / Q000639:trends
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids
keywords: Coronary heart disease; Ezetimibe; Hyperlipidaemia; LDL-cholesterol; Target